| |
| |
|
| Insider
Information: |
Kremer Alton B |
| Relationship: |
VP, Clinical Research |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,302 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$103,738 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,302 |
|
|
| Total
Value |
$103,738 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
VP, Clinical Research |
2008-04-01 |
25,302 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$22,005 |
D/D |
(2,869) |
25,302 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2008-04-01 |
4 |
OE |
$6.52 |
$20,558 |
D/D |
3,153 |
28,171 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2008-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
24,849 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2008-01-02 |
4 |
OE |
$15.36 |
$17,495 |
D/D |
1,139 |
30,885 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$18,679 |
D/D |
(1,036) |
29,849 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$44,302 |
D/D |
2,328 |
31,804 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$47,444 |
D/D |
(2,119) |
29,685 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
29,349 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-07-02 |
4 |
D |
$22.01 |
$17,058 |
D/D |
(775) |
29,426 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-07-02 |
4 |
OE |
$18.71 |
$15,941 |
D/D |
852 |
30,201 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-06-21 |
4 |
D |
$22.46 |
$56,466 |
D/D |
(2,500) |
15,965 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-04-02 |
4 |
OE |
$20.13 |
$46,259 |
D/D |
2,298 |
25,536 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-04-02 |
4 |
D |
$24.10 |
$49,911 |
D/D |
(2,071) |
23,465 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-03-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
18,187 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-01-03 |
4 |
D |
$26.66 |
$16,316 |
D/D |
(612) |
23,187 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2007-01-03 |
4 |
OE |
$21.88 |
$15,010 |
D/D |
686 |
23,799 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,062 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-10-02 |
4 |
D |
$23.03 |
$15,776 |
D/D |
(685) |
13,062 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-10-02 |
4 |
OE |
$19.58 |
$14,724 |
D/D |
752 |
13,747 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
12,948 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-07-03 |
4 |
D |
$24.26 |
$49,709 |
D/D |
(2,049) |
6,448 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-07-03 |
4 |
OE |
$20.45 |
$46,260 |
D/D |
2,262 |
8,497 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-06-21 |
4 |
AS |
$21.60 |
$18,900 |
D/D |
(875) |
6,187 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-04-03 |
4 |
D |
$25.61 |
$14,214 |
D/D |
(555) |
7,062 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Clinical Research |
• – – |
2006-04-03 |
4 |
OE |
$21.77 |
$13,301 |
D/D |
611 |
7,617 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
